human-immunodeficiency-virus

Documents about human-immunodeficiency-virus

• Effect of Evolocumab on Coronary Endothelial Function#848662ClinicalTrials.gov
• GSK1349572 Hepatic Impairment Study#994448ClinicalTrials.gov
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection#857957ClinicalTrials.gov
• CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS#863206ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females#266367ClinicalTrials.gov
• Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)#900039ClinicalTrials.gov
• Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults#226170ClinicalTrials.gov
• Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)#226329ClinicalTrials.gov
• Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects#245575ClinicalTrials.gov
• MAMAS: Mentoring Adolescent Mothers at School#329587ClinicalTrials.gov
• Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV#801917ClinicalTrials.gov
• Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)#807844ClinicalTrials.gov
• Determine the Prevalence and Severity of Asthma in HIV (Human Immunodeficiency Virus) Infected Patients#826842ClinicalTrials.gov
• HIV Prevention in the Primary Care Setting#874810ClinicalTrials.gov
• Feasibility of Telerehabilitation in HIV-patients#881279ClinicalTrials.gov
• Combating Related Epidemics in HCV#881744ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients#855931ClinicalTrials.gov
• PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)#856501ClinicalTrials.gov
• Tissue Drug Levels of HIV Medications#893137ClinicalTrials.gov
• MyPEEPS Mobile for Young Transgender Men#908782ClinicalTrials.gov
• Evaluation of Kaletra Therapy Over the Long-term#915515ClinicalTrials.gov
• Preventive Therapy for Tuberculosis in HIV Infected Persons#918537ClinicalTrials.gov
• Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids#918607ClinicalTrials.gov
• Mathematical Modeling for Human Immunodeficiency Virus (HIV) Transmission using Generating Function Approach#957009SU+ Digital Repository
• A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)#981897ClinicalTrials.gov
• VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1#828958ClinicalTrials.gov
• Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection#864996ClinicalTrials.gov
• Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination#277454Repositorio Universidad Peruana Cayetano Heredia
• Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV#857443ClinicalTrials.gov
• Baseline characteristics of the HOMINY (human papillomavirus, human immunodeficiency virus, and oral microbiota interplay in Nigerian youth) prospective longitudinal cohort.#449912NCBI PubMed Central
• Peripheral Arterial Insufficiency Associated With HIV/AIDS#1009419ClinicalTrials.gov
• Pre-Exposure Prophylaxis Using TMC278LA#806664ClinicalTrials.gov
• Gut Microbiome in People Living With HIV and HBV#844011ClinicalTrials.gov
• The Effect of Ixazomib on the Latent HIV Reservoir#856249ClinicalTrials.gov
• Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection#870184ClinicalTrials.gov
• Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay#882057ClinicalTrials.gov
• Game Plan for PrEP#884932ClinicalTrials.gov
• Drug Interaction Study Between Dolutegravir and an Oral Contraceptive Containing Norgestimate and Ethinylestradiol#893243ClinicalTrials.gov
• 3BNC117 and 10-1074 in ART-treated Individuals#901516ClinicalTrials.gov
• Fosamprenavir Expanded Access#906104ClinicalTrials.gov
• Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice#916780ClinicalTrials.gov
• Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients#967047ClinicalTrials.gov
• A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1#847283ClinicalTrials.gov
• A Study of Co-infections of HIV-1 and Schistosoma Mansoni and Its Impact on Praziquantel Treatment Outcomes#879985ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection#879759ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Food Insecurities#152613ClinicalTrials.gov
• Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV)#804674ClinicalTrials.gov
• Friends for Life Circles for Option B Plus#808037ClinicalTrials.gov
• Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy#832569ClinicalTrials.gov